Literature DB >> 9790922

Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide.

D Derossi1, E J Williams, P J Green, D J Dunican, P Doherty.   

Abstract

The binding of small phosphopeptides to the SH2 domains of the p85 regulatory subunit of PI 3-kinase can activate the enzyme in vitro. In the present study a cell-permeable peptide that binds specifically to the SH2 domains of p85 has been evaluated for its ability to stimulate a mitogenic response in the C2 muscle cell line. This peptide, in contrast to four other SH2-binding peptides, was as effective as serum, EGF, and FGF at stimulating entry into S-phase. The response to the p85 binding peptide, but not FGF, was inhibited by wortmannin and rapamycin, indicating that the peptide activates the PI 3-kinase/S6 kinase signalling pathway. The peptide response was not inhibited by the MEK inhibitor (PD098059) and did not stimulate Erk phosphorylation. Thus, there would appear to be no direct cross-talk between the pathway activated by the p85 binding peptide and the p42/p44 MAPK cascade. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790922     DOI: 10.1006/bbrc.1998.9444

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

2.  Phosphoinositide-dependent pathways in mouse sperm are regulated by egg ZP3 and drive the acrosome reaction.

Authors:  Melissa K Jungnickel; Keith A Sutton; Yanli Wang; Harvey M Florman
Journal:  Dev Biol       Date:  2006-12-15       Impact factor: 3.582

3.  Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides.

Authors:  Guofeng Ye; Nguyen-Hai Nam; Anil Kumar; Ali Saleh; Dinesh B Shenoy; Mansoor M Amiji; Xiaofeng Lin; Gongqin Sun; Keykavous Parang
Journal:  J Med Chem       Date:  2007-06-20       Impact factor: 7.446

4.  Activation of dormant ovarian follicles to generate mature eggs.

Authors:  Jing Li; Kazuhiro Kawamura; Yuan Cheng; Shuang Liu; Cynthia Klein; Shu Liu; En-Kui Duan; Aaron J W Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

5.  Age-independent synaptogenesis by phosphoinositide 3 kinase.

Authors:  Alfonso Martín-Peña; Angel Acebes; José-Rodrigo Rodríguez; Amanda Sorribes; Gonzalo G de Polavieja; Pedro Fernández-Fúnez; Alberto Ferrús
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

6.  Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Antara Banerjee; Arpita Yadav; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

7.  Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism.

Authors:  Reyhaan A Chaudhri; Agreen Hadadi; Kirill S Lobachev; Zvi Schwartz; Barbara D Boyan
Journal:  Biochim Biophys Acta       Date:  2014-08-07

8.  PKCλ is critical in AMPA receptor phosphorylation and synaptic incorporation during LTP.

Authors:  Si-Qiang Ren; Jing-Zhi Yan; Xiao-Yan Zhang; Yun-Fei Bu; Wei-Wei Pan; Wen Yao; Tian Tian; Wei Lu
Journal:  EMBO J       Date:  2013-03-19       Impact factor: 11.598

9.  AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.

Authors:  Alexandra Kitz; Marine de Marcken; Anne-Sophie Gautron; Mitja Mitrovic; David A Hafler; Margarita Dominguez-Villar
Journal:  EMBO Rep       Date:  2016-06-16       Impact factor: 8.807

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.